On Jan. 26, 2021, Eli Lilly announced that bamlanivimab (LY-CoV555) 2800 mg and etesevimab (LY-CoV016) 2800 mg together…
On Jan. 26, 2021, BioReference Laboratories, an OPKO Health company, announced COVID-19 testing agreements for players and officials,…
On Jan. 25, 2021, scientists at the University of Oxford reported that after reviewing interim analyses of both…
On Jan. 25, 2021, Emergent BioSolutions and Humanigen announced a contract development and manufacturing (CDMO) services agreement to…
On Jan. 25, 2021, Nirmidas Biotech announced its second FDA Emergency Use Authorization (EUA) for their COVID-19 rapid…
On Jan. 25, 2021, Merck announced that the company had discontinued development of its SARS-CoV-2/COVID-19 vaccine candidates, V590…
On Jan. 25, 2021, HHMI investigators reported that cholesterol, the waxy compound better known for clogging arteries, helps…
On Jan. 22, 2021, the NIH announced that in large clinical trial conducted worldwide, full dose anti-coagulation (blood…
On Jan. 22, 2021, COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for…
On Jan. 22, 2021, Pfizer and BioNTech announced an advance purchase agreement with COVAX for up to 40…
On Jan. 21, 2021, researchers at the NIH announced they had discovered a new genetic disorder characterized by…
On Jan. 21, 2021, the National Institutes of Health announced results of a small but highly controlled study…
On Jan. 21, 2021, the FDA approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for…
On Jan. 21, 2021, the U.S. Department of Defense (DOD) recommended that adults ages 75 and older should…
On Jan. 21, 2021, NIH researchers announced that after people recover from infection with a virus, the immune…
On Jan. 21, 2021, Eli Lilly announced that bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19…
On Jan. 21, 2021, VBI Vaccines announced that it expected to initiate the first Phase 1/2 clinical study…
On Jan. 21, 2021, Janssen Pharmaceutical announced the FDA had approved CABENUVA (consisting of Janssenﾒs rilpivirine and ViiV…
On Jan. 21, 2021, Penn Medicine reported that patients with inactive cancer and not currently undergoing treatments also…
On Jan. 21, 2021, XBiotech announced that its COVID-19 candidate True Humanﾙ antibody therapy may also be used…
On Jan. 19, 2021, Pfizer and BioNTech announced that results from an in vitro study that provided additional…
On Jan. 19, 2021, a new state of the art institute for antimicrobial research iwasa announced at Oxford…
On Jan. 19, 2021, the Northern Arizona University and TGen, an affiliate of City of Hope, announced results…
On Jan. 19, 2021, ImmunityBio reported findings from a follow-up Molecular Dynamics simulation study of the SARS-CoV-2 spike…
On Jan. 19, 2021, ImmunityBio announced it had received authorization from the South Africa Health Products Regulatory Authority…
On Jan. 19, 2021, Mesa Biotech announced it had received 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA)…
On Jan. 19, 2021, Heat Biologics announced it had transferred its gp96-based COVID-19 vaccine cell line (“ZVX-60”) to…
On Jan, 18, 2021, researchers in Konstanz, Wurzburg, Hamburg and Vienna, led by evolutionary biologist Professor Axel Meyer…
On Jan. 18, 2021, Quest Diagnostics announced that it has entered into an agreement with the Centers for…
On Jan. 15, 2021, scientists studying the bodyﾒs natural defenses against bacterial infection announced they had identified a…